Purpose
to support a Phase 1 trial of a novel injectable formulation of ivermectin to reduce malaria transmission in endemic countries.
Grantee
Division
Global Health
Date
OCTOBER 2026
Region served
GLOBAL
Committed amount
$3,084,852
Grant topic
Malaria
Duration (months)
41
Grantee location
Jacou, France
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.